IPO Proceeds & Why They Matter
| Purpose | Amount |
|---|---|
| New Manufacturing Facility at Bavla, Ahmedabad | Rs. 43.00 Crore* |
| General Corporate Purposes | Balance Amount |
*The disclosed project expenditure exceeds the stated gross issue size of Rs. 41.50 crore. Investors should verify the final funding structure and allocation in the RHP.
Chanakya Interpretation
The IPO is mainly intended to part-finance a new facility for manufacturing sodium metabisulphite, sodium bisulphite powder and ammonium bisulphite. Unlike IPOs used principally for debt repayment or working capital, this investment can directly expand production capacity and support future revenue growth.
However, the company must commission the facility on schedule and secure sufficient demand to achieve healthy utilisation. Delays, cost overruns or lower-than-expected utilisation could affect return ratios.
Business Outlook
Sulphur-based inorganic chemicals have applications across pharmaceuticals, food and beverages, oil drilling, paper manufacturing and water treatment. This diversified demand base gives Shanti Inorganics access to several essential industries.
The company’s strategically located Gujarat facilities provide access to industrial infrastructure, ports, suppliers and customers. Its export business offers another avenue for growth and reduces complete dependence on domestic demand.
The proposed capacity expansion could strengthen its competitive position. Nevertheless, the business remains exposed to raw-material prices, environmental regulations, energy costs and international competition.
Strengths vs Concerns
| 👍 Strengths | ⚠ Concerns |
|---|---|
| Diversified industrial applications | Debt-equity ratio of 0.98 |
| Strong revenue and PAT growth | Borrowings increased substantially |
| Healthy operating margins | Chemical and environmental risks |
| Reasonable post-issue valuation | New-project execution risk |
| Capacity-expansion-led IPO | SME liquidity and volatility |
IPO Valuation
At Rs. 83, Shanti Inorganics will have a post-issue market capitalisation of approximately Rs. 137.42 crore. Based on post-issue EPS of Rs. 4.99, the P/E ratio is around 16.63 times. The price-to-book value is approximately 3.27 times.
The valuation appears reasonable considering FY25 PAT growth of 61%, EBITDA margin of 21.21%, ROE of 38% and ROCE of 27.20%. Future performance will depend on successful commissioning and utilisation of the new facility.
Final Investment View
Shanti Inorganics has reported healthy growth, strong margins and attractive return ratios. Its chemicals serve multiple industries, while the proposed manufacturing facility offers a visible growth opportunity.
The main concerns are rising borrowings, chemical-industry risks and execution of the expansion project. The minimum investment of Rs. 2.66 lakh and SME liquidity risk must also be considered.
Subject to a healthy GMP and satisfactory subscription response, investors with a higher risk appetite may apply.
Chanakya Recommendation: 🟢 Apply
Overall Rating: ⭐⭐⭐⭐☆ (4/5)
Shanti Inorganics IPO FAQs
What is the Shanti Inorganics IPO price band?
The price band is Rs. 79 to Rs. 83 per share.
What is the minimum investment in Shanti Inorganics IPO?
Individual investors must apply for at least 3,200 shares, requiring Rs. 2,65,600 at the upper price.
When will Shanti Inorganics IPO open?
The IPO opens on 31 August and closes on 2 September 2026.
When will Shanti Inorganics shares list?
The tentative listing date is 7 September 2026 on NSE SME.
What is the Chanakya View on Shanti Inorganics IPO?
The IPO carries an Apply recommendation, subject to GMP and subscription demand.